CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01881867 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Castration Levels of Testosterone
Castration-Resistant Prostate Carcinoma
Metastatic Prostate Carcinoma
Stage IV Prostate Cancer

Interventions

BIOLOGICAL: Glycosylated Recombinant Human Interleukin-7
OTHER: Laboratory Biomarker Analysis

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]